Transmission characteristics of MERS and SARS in the healthcare setting: A comparative study

BMC Medicine

Volumn 13, Issue 1, 2015, Pages

  Chowell, Gerardo ^a,b   Abdirizak, Fatima ^a   Lee, Sunmi ^c   Lee, Jonggul ^d   Jung, Eunok ^d   Nishiura, Hiroshi ^e,f   Viboud, Cécile ^b  

^a GEORGIA STATE UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c Kyung Hee University   (South Korea)

^d Konkuk University   (South Korea)

^e UNIVERSITY OF TOKYO   (Japan)

^f JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Coronavirus; Exposure pattern; Hospital transmission; MERS; Middle east; Nosocomial; Reproduction number; SARS; South korea

Indexed keywords

ARTICLE; CANADA; COMPARATIVE STUDY; CORONAVIRUS INFECTION; EPIDEMIC; HOSPITAL INFECTION; INCIDENCE; MIDDLE EAST RESPIRATORY SYNDROME; PROBABILITY; SAUDI ARABIA; SECONDARY INFECTION; SEVERE ACUTE RESPIRATORY SYNDROME; SIMULATION; SINGAPORE; SOUTH KOREA; VIRUS TRANSMISSION; AGED; CROSS INFECTION; FEMALE; HOSPITAL; HUMAN; MALE; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; THEORETICAL MODEL; TRANSMISSION;

AGED; CORONAVIRUS INFECTIONS; CROSS INFECTION; DISEASE OUTBREAKS; FEMALE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MODELS, THEORETICAL; REPUBLIC OF KOREA; SAUDI ARABIA; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 84941261132     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-015-0450-0     Document Type: Article

References (54)

1. Cauchemez S, Fraser C, Van Kerkhove MD, Donnelly CA, Riley S, Rambaut A, et al. Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect Dis. 2014;14:50-6.
2. Kingdom of Saudi Arabia's Ministry of Health. MERS-CoV Statistics; 2015. http://www.moh.gov.sa/en/CCC/Pages/default.aspx . Accessed 15 July 2015.
3. Muller MA, Meyer B, Corman VM, Al-Masri M, Turkestani A, Ritz D, et al. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. Lancet Infect Dis. 2015;15:559-64.
4. Kayali G, Peiris M. A more detailed picture of the epidemiology of Middle East respiratory syndrome coronavirus. Lancet Infect Dis. 2015;15:495-7.
5. Breban R, Riou J, Fontanet A. Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. Lancet. 2013;382:694-9.
6. Chowell G, Blumberg S, Simonsen L, Miller MA, Viboud C. Synthesizing data and models for the spread of MERS-CoV, 2013: key role of index cases and hospital transmission. Epidemics. 2014;9:40-51.
7. Cotten M, Watson SJ, Kellam P, Al-Rabeeah AA, Makhdoom HQ, Assiri A, et al. Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study. Lancet. 2013;382:1993-2002.
8. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367:1814-20.
9. Fisman DN, Tuite AR. The epidemiology of MERS-CoV. Lancet Infect Dis. 2014;14:6-7.
10. Oboho IK, Tomczyk SM, Al-Asmari AM, Banjar AA, Al-Mugti H, Aloraini MS, et al. 2014 MERS-CoV outbreak in Jeddah--a link to health care facilities. N Engl J Med. 2015;372:846-54.
11. Assiri A, McGeer A, Perl TM, Price CS, Al Rabeeah AA, Cummings DA, et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med. 2013;369:407-16.
12. Cowling BJ, Park M, Fang VJ, Wu P, Leung GM, Wu JT. Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015. Euro Surveil. 2015;20.
13. World Health Organization. Global Alert and Response (GAR). Coronavirus infections; 2015. http://www.who.int/csr/don/archive/disease/coronavirus_infections/en/ . Accessed 15 June 2015.
14. Ministry of Health & Welfare of South Korea. Information on Middle East respiratory syndrome (MERS) reported in South Korea. http://english.mw.go.kr . Accessed 15 July 2015.
15. Sang-Hun C. South Korea confirms 2 more deaths in MERS outbreak. The New York Times. 2015. http://www.nytimes.com/2015/06/05/world/asia/south-korea-mers-virus-death.html?_r=0 . Accessed 5 June 2015.
16. Goh KT, Cutter J, Heng BH, Ma S, Koh BK, Kwok C, et al. Epidemiology and control of SARS in Singapore. Ann Acad Med Singapore. 2006;35:301-16.
17. Varia M, Wilson S, Sarwal S, McGeer A, Gournis E, Galanis E, et al. Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada. CMAJ. 2003;169:285-92.
18. de Wit E, Rasmussen AL, Falzarano D, Bushmaker T, Feldmann F, Brining DL, et al. Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques. Proc Natl Acad Sci U S A. 2013;110:16598-603.
19. Franks TJ, Chong PY, Chui P, Galvin JR, Lourens RM, Reid AH, et al. Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum Pathol. 2003;34:743-8.
20. Zumla A, Hui D, Perlman S. Middle East respiratory syndrome. Lancet, in press. doi:10.1016/S0140-6736(15)60454-8 2015.
21. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013;13:752-61.
22. Donnelly CA, Ghani AC, Leung GM, Hedley AJ, Fraser C, Riley S, et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet. 2003;361:1761-6.
23. Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM. Superspreading and the effect of individual variation on disease emergence. Nature. 2005;438:355-9.
24. Fisman DN, Leung GM, Lipsitch M. Nuanced risk assessment for emerging infectious diseases. Lancet. 2014;383:189-90.
25. Kucharski AJ, Althaus CL. The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission. Euro Surveil. 2015;20.
26. Nishiura H MY, Chowell G, Saitoh M. Assessing the risk of observing multiple generations of Middle East respiratory syndrome (MERS) cases given an imported case. Euro Surveil. 2015;20.
27. Kingdom of Saudi Arabia's Ministry of Health. Update in Statistics: Ministry of Health Institutes new standards for reporting of MERS-CoV. 2014. http://www.moh.gov.sa/en/CCC/News/Pages/News-2014-06-03-001.aspx . Accessed on 5 June 2015.
28. World Health Organization. Revised case definition for reporting to WHO-Middle East respiratory syndrome coronavirus; 2015. http://www.who.int/csr/disease/coronavirus_infections/case_definition/en/ . Accessed on 5 June 2015.
29. World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. 2003. http://www.who.int/csr/sars/country/table2004_04_21/en/ . Accessed 5 June 2015.
30. World Health Organization. Case definitions for surveillance of severe acute respiratory syndrome (SARS); 2003. http://www.who.int/csr/sars/casedefinition/en/ . Accessed 5 June 2015.
31. Anderson RM, May RM. Infectious diseases of humans. Oxford: Oxford University Press; 1991.
32. Nishiura H, Chowell G, Heesterbeek H, Wallinga J. The ideal reporting interval for an epidemic to objectively interpret the epidemiological time course. J R Soc Interface. 2010;7:297-307.
33. FluTrackers. South Korea Coronavirus MERS Case List - including imported and exported cases; 2015. https://flutrackers.com/forum/forum/novel-coronavirus-ncov-mers-2012-2014/novel-coronavirus-who-chp-wpro-ecdc-oie-fao-moa-reports-and-updates/south-korea-coronavirus/732065-south-korea-coronavirus-mers-case-list-including-imported-and-exported-cases . Accessed 15 July 2015.
34. Korean Centers for Disease Control. Middle East Respiratory Syndrome Report [09 June 2015]. http://www.cdc.go.kr/CDC/notice/CdcKrIntro0201.jsp?menuIds=HOME001-MNU1154-MNU0005-MNU0011&fid=21&q_type=&q_value=&cid=63295&pageNum= . Accessed 15 June 2015.
35. Blumberg S, Lloyd-Smith JO. Inference of R(0) and transmission heterogeneity from the size distribution of stuttering chains. PLoS Comput Biol. 2013;9, e1002993.
36. Lee ML, Chen CJ, Su IJ, Chen KT, Yeh CC, King CC, et al. Severe acute respiratory syndrome -Taiwan, 2003. Morbidity and Mortality Weekly Report (MMWR). 2003; 52:461-6.
37. McDonald LC, Simor AE, Su IJ, Maloney S, Ofner M, Chen KT, et al. SARS in healthcare facilities, Toronto and Taiwan. Emerg Infect Dis. 2004;10:777-81.
38. Gopalakrishna G, Choo P, Leo YS, Tay BK, Lim YT, Khan AS, et al. SARS transmission and hospital containment. Emerg Infect Dis. 2004;10:395-400.
39. Blumberg S, Lloyd-Smith JO. Comparing methods for estimating R0 from the size distribution of subcritical transmission chains. Epidemics. 2013;5:131-45.
40. Althaus CL. Ebola superspreading. Lancet Infect Dis. 2015;15:507-8.
41. Lipsitch M, Cohen T, Cooper B, Robins JM, Ma S, James L, et al. Transmission dynamics and control of severe acute respiratory syndrome. Science. 2003;300:1966-70.
42. Riley S, Fraser C, Donnelly CA, Ghani AC, Abu-Raddad LJ, Hedley AJ, et al. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science. 2003;300:1961-6.
43. Majumder MS, Rivers C, Lofgren E, Fisman D. Estimation of MERS-coronavirus reproductive number and case fatality rate for the Spring 2014 Saudi Arabia outbreak: insights from publicly available data. PLoS Curr. 2014;6.
44. Park M. South Korea grapples to contain MERS as 1,369 in quarantine. CNN. 2015. http://edition.cnn.com/2015/06/03/world/south-korea-mers/ . Accessed 5 June 2015.
45. Nishiura H, Kuratsuji T, Quy T, Phi NC, Van Ban V, Ha LE, et al. Rapid awareness and transmission of severe acute respiratory syndrome in Hanoi French Hospital, Vietnam. Am J Trop Med Hyg. 2005;73:17-25.
46. Chowell G, Fenimore PW, Castillo-Garsow MA, Castillo-Chavez C. SARS outbreaks in Ontario, Hong Kong and Singapore: the role of diagnosis and isolation as a control mechanism. J Theor Biol. 2003;224:1-8.
47. Gumel AB, Ruan S, Day T, Watmough J, Brauer F, van den Driessche P, et al. Modelling strategies for controlling SARS outbreaks. Proc Biol Sci. 2004;271:2223-32.
48. Cori A, Boelle PY, Thomas G, Leung GM, Valleron AJ. Temporal variability and social heterogeneity in disease transmission: the case of SARS in Hong Kong. PLoS Comput Biol. 2009;5, e1000471.
49. World Health Organization. Infection prevention and control of epidemic-and pandemic prone acute respiratory infections in health care. WHO Guidelines. 2014. http://apps.who.int/iris/bitstream/10665/112656/1/9789241507134_eng.pdf?ua=1 Accessed 5 June 2015.
50. CDC. Interim infection prevention and control recommendations for hospitalized patients with Middle East respiratory syndrome coronavirus (MERS-CoV). 2014. http://www.cdc.gov/coronavirus/mers/infection-prevention-control.html . Accessed 5 June 2015.
51. Wong T, Wallington T, McDonald LC, Abbas Z, Christian M, Low DE, et al. Late recognition of SARS in nosocomial outbreak,Toronto. Emerg Infect Dis. 2005;11:322-5.
52. Zeng G, Xie SY, Li Q, Ou JM. Infectivity of severe acute respiratory syndrome during its incubation period. Biomed Environ Sci. 2009;22:502-10.
53. Tuan PA, Horby P, Dinh PN, Mai LT, Zambon M, Shah J, et al. SARS transmission in Vietnam outside of the health-care setting. Epidemiol Infect. 2007;135:392-401.
54. Leung GM, Hedley AJ, Ho LM, Chau P, Wong IO, Thach TQ, et al. The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients. Ann Intern Med. 2004;141:662-73.